Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
NCT07217717
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Pancreatic Ductal Adenocarcinoma (PDAC)
Interventions
DRUG:
[18F]FAPI-74 PET/CT
Sponsor
SOFIE